Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Blood drug"'
Autor:
Lingling Pei, Weijie Zhou
Publikováno v:
Soft Computing. 24:4977-4990
The Verhulst model is used in many natural and social systems. When simulating and predicting system sequences with an inverted U shape or a signal peak feature by the grey Verhulst model (abbreviated as GVM), such as the pig price index, a drift phe
Autor:
Richard M. Weinshilboum, Meenal Gupta, Anthony Batzler, Joanna M. Biernacka, Drew Neavin, Yusuke Nakamura, Wayne R. Matson, Michelle K. Skime, William V. Bobo, Duan Liu, Mark A. Frye, Hongjie Zhu, Krishna R. Kalari, Greg D. Jenkins, Liewei Wang, Daniel K. Hall-Flavin, T Mushiroda, Swati S. Bhasin, Michiaki Kubo, Rima Kaddurah-Daouk
Publikováno v:
Molecular Psychiatry
Millions of patients suffer from major depressive disorder (MDD), but many do not respond to selective serotonin reuptake inhibitor (SSRI) therapy. We used a pharmacometabolomics-informed pharmacogenomics research strategy to identify genes associate
Publikováno v:
Forensic Toxicology. 33:131-140
Forensic toxicology involves two possible levels of interpretation: qualitative (detection of xenobiotic consumption by the victim) and quantitative (assessing the implication of xenobiotics in death). Based on six drugs (meprobamate, morphine, cyame
Publikováno v:
Pituitary
The study was designed to evaluate the long-term efficacy and safety of the 28-day prolonged-release Autogel formulation of the somatostatin analogue lanreotide (Lan-Autogel) in unselected patients with acromegaly. The study comprised four phases: wa
Publikováno v:
Journal of Materials Science: Materials in Medicine. 26
A suitable drug-loaded scaffold that can postoperatively release an antituberculosis drug efficiently in a lesion area and help repair a bone defect is very important in the clinical treatment of bone tuberculosis (TB). In this study, a composite dru
Autor:
Ken-ichi Inui, Masahide Fukudo, Yasuhiro Ogura, Satohiro Masuda, Sachio Fukatsu, Toshiya Katsura, Fumitaka Oike, Yasutsugu Takada, Koichi Tanaka, Ikuko Yano
Publikováno v:
Clinical Pharmacology & Therapeutics. 78:168-181
Background The calcineurin inhibitors tacrolimus and cyclosporine (INN, ciclosporin) have been widely used to prevent allograft rejection after transplantation. We investigated pharmacodynamic properties of the 2 drugs and their clinical relevance in
Autor:
Jørgen G. Bramness, Jørg Mørland, Harald Breilid, Svetlana Skurtveit, Margaretha Gulliksen, Vidar M. Steen
Publikováno v:
European Journal of Clinical Pharmacology. 61:499-506
The aim of the present study was to investigate if subjects with one normal and one non-functional CYP2C19 allele (intermediate metabolizers; IMs) metabolized carisoprodol differently than individuals with two normal CYP2C19 alleles (extensive metabo
Autor:
Alexandros D. Tselepis, C. Tzallas, C Petris, S.-A. Karabina, Elisaf, Eleni Bairaktari, Kostas C. Siamopoulos
Publikováno v:
Journal of Human Hypertension. 13:781-785
Moxonidine is a new antihypertensive agent whose mechanism of action appears to involve specific stimulation of imidazoline receptors resulting in an inhibition of the activity of the central and peripheral sympathetic nervous system. The drug seems
Autor:
Steven B. Karch
Publikováno v:
Forensic Science, Medicine, and Pathology. 9:256-257
Dr. Roger Byard has written a comprehensive and uncontroversial review [1]. There is little new, useful or controversial I can add. However, based upon my own experiences I can discuss some of the consequences of what he has said which, as all of you
Publikováno v:
Critical Care
Critical care, 14 (6
Critical care, 14 (6
The major interventional trials of intensive insulin therapy in critically ill patients have reached divergent results. The present viewpoint article explores some of the potential reasons, including differences in monitoring technology and protocol